Literature DB >> 24427047

1-Allyl-3-chloro-5-nitro-1H-indazole.

Hakima Chicha1, El Mostapha Rakib1, Domenico Spinelli2, Mohamed Saadi3, Lahcen El Ammari3.   

Abstract

In the title compound, C10H8ClN3O2, the indazole ring system makes a dihedral angle of 7.9 (3)° with the plane through the nitro group. The allyl group is rotated out of the plane of the indazole ring system [N-N-C-C torsion angle = 104.28 (19)°]. In the crystal, mol-ecules are linked by C-H⋯O hydrogen bonds, forming zigzag chains propagating along the b-axis direction.

Entities:  

Year:  2013        PMID: 24427047      PMCID: PMC3884460          DOI: 10.1107/S1600536813021995

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the pharmacological activity of indazole derivatives, see: Baraldi et al. (2001 ▶); Rodgers et al. (1996 ▶); Li et al. (2003 ▶); Lin et al. (2008 ▶). For a similar compound, see: El Brahmi et al. (2012 ▶).

Experimental

Crystal data

C10H8ClN3O2 M = 237.64 Monoclinic, a = 13.3025 (6) Å b = 11.2505 (5) Å c = 7.3092 (3) Å β = 91.343 (2)° V = 1093.59 (8) Å3 Z = 4 Mo Kα radiation μ = 0.34 mm−1 T = 296 K 0.41 × 0.34 × 0.22 mm

Data collection

Bruker X8 APEX diffractometer Absorption correction: multi-scan (SADABS: Sheldrick, 2008 ▶) T min = 0.654, T max = 0.747 14430 measured reflections 3069 independent reflections 1852 reflections with I > 2σ(I) R int = 0.046

Refinement

R[F 2 > 2σ(F 2)] = 0.047 wR(F 2) = 0.136 S = 1.02 3069 reflections 145 parameters H-atom parameters constrained Δρmax = 0.27 e Å−3 Δρmin = −0.33 e Å−3 Data collection: APEX2 (Bruker, 2009 ▶); cell refinement: SAINT (Bruker, 2009 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012 ▶); software used to prepare material for publication: PLATON (Spek, 2009 ▶) and publCIF (Westrip, 2010 ▶). Crystal structure: contains datablock(s) I. DOI: 10.1107/S1600536813021995/bt6927sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536813021995/bt6927Isup2.hkl Click here for additional data file. Supplementary material file. DOI: 10.1107/S1600536813021995/bt6927Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C10H8ClN3O2F(000) = 488
Mr = 237.64Dx = 1.443 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 3069 reflections
a = 13.3025 (6) Åθ = 2.4–29.6°
b = 11.2505 (5) ŵ = 0.34 mm1
c = 7.3092 (3) ÅT = 296 K
β = 91.343 (2)°Block, colourless
V = 1093.59 (8) Å30.41 × 0.34 × 0.22 mm
Z = 4
Bruker X8 APEX diffractometer3069 independent reflections
Radiation source: fine-focus sealed tube1852 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.046
φ and ω scansθmax = 29.6°, θmin = 2.4°
Absorption correction: multi-scan (SADABS: Sheldrick, 2008)h = −18→18
Tmin = 0.654, Tmax = 0.747k = −10→15
14430 measured reflectionsl = −9→10
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.047Hydrogen site location: difference Fourier map
wR(F2) = 0.136H-atom parameters constrained
S = 1.02w = 1/[σ2(Fo2) + (0.069P)2 + 0.0517P] where P = (Fo2 + 2Fc2)/3
3069 reflections(Δ/σ)max < 0.001
145 parametersΔρmax = 0.27 e Å3
0 restraintsΔρmin = −0.33 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against all reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on all data will be even larger.
xyzUiso*/Ueq
C10.39644 (11)0.25338 (16)1.0420 (2)0.0451 (4)
C20.29681 (11)0.22952 (14)0.97697 (19)0.0415 (4)
C30.24119 (12)0.12846 (15)0.9339 (2)0.0462 (4)
H30.26810.05250.94500.055*
C40.14423 (13)0.14758 (16)0.8741 (2)0.0517 (4)
C50.10115 (12)0.26115 (18)0.8562 (2)0.0549 (5)
H50.03460.26850.81600.066*
C60.15549 (13)0.36043 (16)0.8970 (2)0.0508 (4)
H60.12780.43600.88480.061*
C70.25499 (12)0.34380 (14)0.9583 (2)0.0428 (4)
C80.32262 (15)0.55248 (16)1.0068 (3)0.0596 (5)
H8A0.37940.58461.07630.071*
H8B0.26160.57851.06500.071*
C90.32387 (17)0.59986 (17)0.8194 (3)0.0666 (5)
H90.38140.58660.75260.080*
C100.2520 (2)0.6582 (2)0.7404 (5)0.1088 (10)
H10A0.19310.67340.80250.131*
H10B0.25880.68520.62100.131*
N10.32739 (10)0.42252 (13)1.01153 (19)0.0492 (4)
N20.41482 (10)0.36715 (13)1.06173 (19)0.0503 (4)
N30.08324 (14)0.04395 (18)0.8226 (2)0.0720 (5)
O10.12321 (14)−0.05345 (16)0.8167 (3)0.0968 (6)
O2−0.00516 (13)0.06089 (18)0.7844 (3)0.1118 (7)
Cl10.48743 (3)0.15046 (5)1.08995 (7)0.0677 (2)
U11U22U33U12U13U23
C10.0412 (8)0.0522 (10)0.0417 (8)0.0014 (7)−0.0009 (6)0.0049 (7)
C20.0419 (8)0.0462 (9)0.0364 (7)−0.0014 (7)0.0006 (6)0.0022 (7)
C30.0520 (10)0.0463 (9)0.0404 (8)−0.0039 (7)0.0034 (7)0.0008 (7)
C40.0497 (10)0.0619 (12)0.0435 (8)−0.0181 (8)0.0021 (7)−0.0055 (8)
C50.0388 (9)0.0757 (13)0.0500 (10)−0.0016 (9)−0.0047 (7)−0.0016 (9)
C60.0458 (9)0.0567 (11)0.0498 (9)0.0071 (8)−0.0024 (7)0.0017 (8)
C70.0428 (8)0.0458 (9)0.0398 (8)−0.0012 (7)−0.0008 (6)0.0017 (7)
C80.0678 (12)0.0427 (10)0.0679 (12)−0.0045 (8)−0.0037 (9)−0.0069 (8)
C90.0795 (14)0.0424 (11)0.0778 (13)−0.0081 (10)−0.0029 (11)0.0029 (10)
C100.139 (3)0.0582 (14)0.127 (2)−0.0137 (14)−0.056 (2)0.0176 (14)
N10.0485 (8)0.0440 (8)0.0548 (8)−0.0036 (6)−0.0071 (6)0.0020 (6)
N20.0438 (8)0.0544 (9)0.0523 (8)−0.0044 (6)−0.0057 (6)0.0045 (7)
N30.0667 (11)0.0798 (13)0.0694 (11)−0.0279 (10)0.0027 (9)−0.0118 (10)
O10.0979 (12)0.0673 (11)0.1254 (15)−0.0298 (10)0.0049 (11)−0.0242 (10)
O20.0639 (10)0.1174 (15)0.1528 (18)−0.0334 (10)−0.0243 (10)−0.0240 (12)
Cl10.0516 (3)0.0709 (4)0.0803 (4)0.0142 (2)−0.0084 (2)0.0080 (2)
C1—N21.310 (2)C7—N11.359 (2)
C1—C21.423 (2)C8—N11.464 (2)
C1—Cl11.7056 (17)C8—C91.470 (3)
C2—C31.389 (2)C8—H8A0.9700
C2—C71.406 (2)C8—H8B0.9700
C3—C41.369 (2)C9—C101.286 (3)
C3—H30.9300C9—H90.9300
C4—C51.405 (3)C10—H10A0.9300
C4—N31.465 (2)C10—H10B0.9300
C5—C61.360 (2)N1—N21.3621 (19)
C5—H50.9300N3—O21.217 (2)
C6—C71.400 (2)N3—O11.219 (2)
C6—H60.9300
N2—C1—C2113.02 (14)C6—C7—C2121.48 (15)
N2—C1—Cl1120.71 (12)N1—C8—C9112.52 (16)
C2—C1—Cl1126.27 (14)N1—C8—H8A109.1
C3—C2—C7121.26 (15)C9—C8—H8A109.1
C3—C2—C1135.84 (16)N1—C8—H8B109.1
C7—C2—C1102.90 (14)C9—C8—H8B109.1
C4—C3—C2115.89 (16)H8A—C8—H8B107.8
C4—C3—H3122.1C10—C9—C8125.4 (3)
C2—C3—H3122.1C10—C9—H9117.3
C3—C4—C5123.49 (16)C8—C9—H9117.3
C3—C4—N3117.96 (18)C9—C10—H10A120.0
C5—C4—N3118.54 (17)C9—C10—H10B120.0
C6—C5—C4120.86 (16)H10A—C10—H10B120.0
C6—C5—H5119.6C7—N1—N2111.97 (13)
C4—C5—H5119.6C7—N1—C8127.90 (15)
C5—C6—C7117.01 (16)N2—N1—C8119.96 (14)
C5—C6—H6121.5C1—N2—N1105.13 (13)
C7—C6—H6121.5O2—N3—O1123.54 (19)
N1—C7—C6131.54 (16)O2—N3—C4117.4 (2)
N1—C7—C2106.97 (14)O1—N3—C4119.02 (18)
D—H···AD—HH···AD···AD—H···A
C6—H6···O2i0.932.463.274 (2)146
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
C6—H6⋯O2i 0.932.463.274 (2)146

Symmetry code: (i) .

  5 in total

1.  Structure-based design, synthesis, and antimicrobial activity of indazole-derived SAH/MTA nucleosidase inhibitors.

Authors:  Xiaoming Li; Sam Chu; Victoria A Feher; Mitra Khalili; Zhe Nie; Stephen Margosiak; Victor Nikulin; James Levin; Kelly G Sprankle; Martina E Tedder; Robert Almassy; Krzysztof Appelt; Kraig M Yager
Journal:  J Med Chem       Date:  2003-12-18       Impact factor: 7.446

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders.

Authors:  P G Baraldi; G Balboni; M G Pavani; G Spalluto; M A Tabrizi; E D Clercq; J Balzarini; T Bando; H Sugiyama; R Romagnoli
Journal:  J Med Chem       Date:  2001-08-02       Impact factor: 7.446

4.  1-Allyl-6-nitro-1H-indazole.

Authors:  Nabil El Brahmi; Mohammed Benchidmi; El Mokhtar Essassi; Sonia Ladeira; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-11-17

5.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  5 in total
  3 in total

1.  2-Allyl-7-nitro-2H-indazole.

Authors:  Assoman Kouakou; El Mostapha Rakib; Domenico Spinelli; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-10-02

2.  6,6'-Di-nitro-1,1'-(ethane-1,2-di-yl)di(1H-indazole).

Authors:  Assoman Kouakou; El Mostapha Rakib; Abdelghani El Malki; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-03-05

3.  Crystal structure of triethyl 2-(5-nitro-2H-indazol-2-yl)propane-1,2,3-tri-carboxyl-ate.

Authors:  Mohammed Boulhaoua; Mohammed Benchidmi; El Mokhtar Essassi; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-09-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.